Luye Pharma Group(LYPHF)
$0.270.00 (0.00%)
LYPHF
Luye Pharma Group stock forecast
$0.27
At close:0.00 (0.00%)
Luye Pharma Group (LYPHF) Stock Forecast & Price Target
4 Followers
LYPHF Analyst Ratings
Hold
0Buy1Hold0Sell
Based on 1 analysts giving stock ratings to Luye Pharma Group in the past 3 months
LYPHF Stock 12 Month Forecast
Average Price Target
$0.30▲(9.99% Upside)Based on 1 Wall Street analysts offering 12 month price targets for Luye Pharma Group in the last 3 months. The average price target is $0.30 with a high forecast of $0.30 and a low forecast of $0.30. The average price target represents a 9.99% change from the last price of $0.27.
Past 12 Months12 Month ForecastJan2026Oct2026
High$0.30
Average$0.30
Low$0.30
Highest Price TargetHighest$0.30Average Price Target$0.30Lowest Price TargetLowest$0.30
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
LYPHF Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 0 | 0 | 0 |
| Buy | 2 | 2 | 2 | 0 | 0 |
| Hold | 0 | 0 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 3 | 3 | 3 | 1 | 1 |
In the current month, LYPHF has received 0 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. LYPHF average Analyst price target in the past 3 months is 0.30.
LYPHF Financial Forecast
High$0.01
Consensus$0.01
Low$0.01
LYPHF Earnings Forecast
Next quarter’s earnings estimate for LYPHF is $0.01 with a range of $0.01 to $0.01. The previous quarter’s EPS was $0.00. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
High$475M
Consensus$475M
Low$475M
LYPHF Sales Forecast
Next quarter’s sales forecast for LYPHF is $474.89M with a range of $474.89M to $474.89M. The previous quarter’s sales results were $436.20M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
LYPHF Stock Forecast FAQ
What is LYPHF’s average 12-month price target, according to analysts?
Based on analyst ratings, Luye Pharma Group’s 12-month average price target is $0.30.
What is LYPHF’s upside potential, based on the analysts’ average price target?
Luye Pharma Group has 9.99% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is LYPHF a Buy, Sell or Hold?
Luye Pharma Group has a consensus rating of Hold which is based on 0 buy ratings, 1 hold ratings and 0 sell ratings.
What is Luye Pharma Group’s price target?
The average price target for Luye Pharma Group is $0.30. This is based on 1 12-month price targets, issued in the past 3 months. The highest analyst price target is $0.30, the lowest forecast is $0.30. The average price target represents a 9.99% increase from the current price of $0.27.
What do analysts say about Luye Pharma Group?
Luye Pharma Group’s analyst rating consensus is a Hold. This is based on the ratings of 1 Wall Street analysts.
How can I buy shares of LYPHF?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
